An interventional study of Spinal Cord Stimulation and Spinal Fusion Surgery in Failed Back Surgery Syndrome, SCS and Neuromodulation, sponsored by University Hospital Augsburg. Recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-04-14.
Sponsored by University Hospital Augsburg · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Low back pain affects people of all ages and has become the leading cause of living with disability worldwide. Patients, suffering from persistent pain after spinal surgery in the absence of any clear spinal pathology are defined of having a "failed back surgery syndrome (FBSS)" and treatment of FBSS remains a great controversy in the spinal community. Apart from conservative treatment, spinal fusion remains as therapeutic option. Furthermore, minimal invasive Neuromodulation techniques might be a promising alternative. Aim of this randomized interventional multi center study is to compare treatment success in FBSS patients with either spinal cord stimulation (SCS) or fusion surgery, 12 months after intervention according to the Oswestry Disability Index (ODI) and other scales and scores. Radiological and health economic outcome also will be analysed for thorough comparison of techniques. Additionally, the safety of the interventions needs to be compared.
104 studies on the registry are indexed under Failed Back Surgery Syndrome; 15 are open to participants now.
This study's planned enrollment of 84 is above the median of 40 across 75 interventional studies indexed under Failed Back Surgery Syndrome.
Browse Failed Back Surgery Syndrome studies →University Hospital Augsburg is the lead sponsor of 25 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The spinal cord stimulators WaveWriter AlphaTM (Boston Scientific) are designed to treat chronic back or leg pain by electrically stimulating the spinal cord. It is a well established worldwide licensed device. Percutaneous lead(-s) are implanted in the epidural space of the thoracic spine during the initial procedure. After discharge a trial phase is initiated and performed according to local preferences and standard of operations (SOPs). Patients are monitored for any complications and pain reduction. If a significant pain reduction (\>50 % on the NRS scale for back pain) is achieved, the permanent implantable pulse generator (IPG) is implanted. Otherwise if the therapy remains non-beneficial throughout the trial phase, the leads will be explanted. Patients are allowed to crossover in the fusion group at any point of time.
Device: Spinal Cord Stimulation
The control group needs to represent the standard of care of current practice. Gold standard is lumbar fusion surgery \[Resnik 2005\]. Surgical instrumentation will be performed according to local preferences and SOPs. Safety and efficacy of these fusion techniques have been repeatedly proven
Procedure: Spinal Fusion Surgery
Epidural application of electrical current to the spinal cord
Also known as: SCS
screw-rod system based spinal instrumentation
Oswestry disability index / ODI
A patient reported outcome measure to rate pain and disability
Time frame: 12 months after intervention
Adverse events
Comparison of complication rates
Time frame: 12 months after intervention
SF36
Score to assess quality of life
Time frame: 12 months after intervention
EuroQOL 5D
Score to assess quality of life
Time frame: 12 months after intervention
hospital length of stay
Time measured in days, counting from the first day of hospitalization until the day of discharge of the hospitalization the surgical intervention was performed. If surgery is performed as staged procedure in two separate hospitalizations (SCS) both hospitalizations are counted as described above and days are summed up.
Time frame: through study completion, an average of 2 years
Crossover rates
Rates of crossover to another therapy arm
Time frame: 12 months after intervention
Pain medication
Amount of analgesics taken (drug, dose, mode of application)
Time frame: 12 months after intervention
Plan to share: No
Started Mar 2023 (actual). Primary completion is estimated for Nov 2024, 20 months after the start.
Of 36 non-industry interventional studies with no phase under Failed Back Surgery Syndrome, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 52. This study's planned 20 months is below that.
Counting every sponsor, half of 38 studies reached it within 23 months; a quarter within 12 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Failed Back Surgery Syndrome →
University Hospital Augsburg